BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31941968)

  • 1. CD40L membrane retention enhances the immunostimulatory effects of CD40 ligation.
    Elmetwali T; Salman A; Wei W; Hussain SA; Young LS; Palmer DH
    Sci Rep; 2020 Jan; 10(1):342. PubMed ID: 31941968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD40 signalling induces IL-10-producing, tolerogenic dendritic cells.
    Tuettenberg A; Fondel S; Steinbrink K; Enk AH; Jonuleit H
    Exp Dermatol; 2010 Jan; 19(1):44-53. PubMed ID: 19889024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
    Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Presentation of tumor antigens by dendritic cells genetically modified with viral and nonviral vectors.
    Lotem M; Zhao Y; Riley J; Hwu P; Morgan RA; Rosenberg SA; Parkhurst MR
    J Immunother; 2006; 29(6):616-27. PubMed ID: 17063124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated platelets rapidly up-regulate CD40L expression and can effectively mature and activate autologous ex vivo differentiated DC.
    Martinson J; Bae J; Klingemann HG; Tam Y
    Cytotherapy; 2004; 6(5):487-97. PubMed ID: 15512915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendritic cells cultured in anti-CD40 antibody-immobilized plates elicit a highly efficient peptide-specific T-cell response.
    Osada T; Nagawa H; Takahashi T; Tsuno NH; Kitayama J; Shibata Y
    J Immunother; 2002; 25(2):176-84. PubMed ID: 12074047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased production of pro-inflammatory cytokines and enhanced T cell responses after activation of human dendritic cells with IL-1 and CD40 ligand.
    Wesa A; Galy A
    BMC Immunol; 2002 Oct; 3():14. PubMed ID: 12385649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles virus induces abnormal differentiation of CD40 ligand-activated human dendritic cells.
    Servet-Delprat C; Vidalain PO; Bausinger H; Manié S; Le Deist F; Azocar O; Hanau D; Fischer A; Rabourdin-Combe C
    J Immunol; 2000 Feb; 164(4):1753-60. PubMed ID: 10657621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of monocyte-derived dendritic cells and activated T cells which express CD40 ligand: a new approach to cancer immunotherapy.
    Sato T; Terai M; Yasuda R; Watanabe R; Berd D; Mastrangelo MJ; Hasumi K
    Cancer Immunol Immunother; 2004 Jan; 53(1):53-61. PubMed ID: 13680192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.
    Tada Y; O-Wang J; Yu L; Shimozato O; Wang YQ; Takiguchi Y; Tatsumi K; Kuriyama T; Takenaga K; Sakiyama S; Tagawa M
    Cancer Gene Ther; 2003 Jun; 10(6):451-6. PubMed ID: 12768190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-1 beta enhances CD40 ligand-mediated cytokine secretion by human dendritic cells (DC): a mechanism for T cell-independent DC activation.
    Luft T; Jefford M; Luetjens P; Hochrein H; Masterman KA; Maliszewski C; Shortman K; Cebon J; Maraskovsky E
    J Immunol; 2002 Jan; 168(2):713-22. PubMed ID: 11777965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IFN-alpha enhances CD40 ligand-mediated activation of immature monocyte-derived dendritic cells.
    Luft T; Luetjens P; Hochrein H; Toy T; Masterman KA; Rizkalla M; Maliszewski C; Shortman K; Cebon J; Maraskovsky E
    Int Immunol; 2002 Apr; 14(4):367-80. PubMed ID: 11934873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human dendritic cells that simultaneously secrete IL-12 and have migratory capacity by adenoviral gene transfer of hCD40L in combination with IFN-gamma.
    Knippertz I; Hesse A; Schunder T; Kämpgen E; Brenner MK; Schuler G; Steinkasserer A; Nettelbeck DM
    J Immunother; 2009 Jun; 32(5):524-38. PubMed ID: 19609245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NORE1A induction by membrane-bound CD40L (mCD40L) contributes to CD40L-induced cell death and G1 growth arrest in p21-mediated mechanism.
    Elmetwali T; Salman A; Palmer DH
    Cell Death Dis; 2016 Mar; 7(3):e2146. PubMed ID: 26986513
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD40 signalling in ileal Peyer's patch B cells: implications for T cell-dependent antigen selection.
    Griebel P; Ferrari G
    Int Immunol; 1995 Mar; 7(3):369-79. PubMed ID: 7540860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent delivery of tumor antigens and activation signals to dendritic cells by irradiated CD40 ligand-transfected tumor cells resulted in efficient activation of specific CD8+ T cells.
    Liu KJ; Lu LF; Cheng HT; Hung YM; Shiou SR; Whang-Peng J; Juang SH
    Cancer Gene Ther; 2004 Feb; 11(2):135-47. PubMed ID: 14647233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha and CD40 ligand antagonize the inhibitory effects of interleukin 10 on T-cell stimulatory capacity of dendritic cells.
    Brossart P; Zobywalski A; Grünebach F; Behnke L; Stuhler G; Reichardt VL; Kanz L; Brugger W
    Cancer Res; 2000 Aug; 60(16):4485-92. PubMed ID: 10969796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
    Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
    J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.